Toxicity Profile | List of Frontiers open access articles

Original Research

Published on 10 Oct 2023

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study

in Drugs Outcomes Research and Policies

Hao Liu
Yumin Li
Jie Li
Qiongchi Zhang
Jingtao Wu
Xinyu Li
Liesu Meng
Shuai Cao
Haopeng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199031

9,209 views
28 citations

Systematic Review

Published on 10 Nov 2022

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Tongzhen Xu
Yunsong Liu
Xiaotong Lu
Jun Liang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1039020

6,202 views
14 citations

Original Research

Published on 23 Jul 2021

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma

in Radiation Oncology

Jiyi Hu
Qingting Huang
Jing Gao
Weixu Hu
Jing Yang
Xiyin Guan
Xianxin Qiu
Wenna Zhang
Lin Kong
Jiade J. Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.653050

4,243 views
13 citations

Review

Published on 06 Oct 2022

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia

in Hematologic Malignancies

Kota Yoshifuji
Koji Sasaki

Frontiers in Oncology

doi 10.3389/fonc.2022.1021662

7,475 views
6 citations

Case Report

Published on 07 Jun 2023

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

in Radiation Oncology

Yejun Hong
Nancy Nixon
Jeffrey Q. Cao
Sangjune Laurence Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1171444

5,199 views
3 citations

Mini Review

Published on 18 Sep 2019

Effect on Platelet Function of Metal-Based Nanoparticles Developed for Medical Applications

in Atherosclerosis and Vascular Medicine

Nadhim Kamil Hante
Carlos Medina
Maria Jose Santos-Martinez

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2019.00139

9,383 views
34 citations

Mini Review

Published on 21 Jul 2014

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

in Thoracic Oncology

Normand Blais
Vera Hirsh

Frontiers in Oncology

doi 10.3389/fonc.2014.00177

11,256 views
7 citations

Original Research

Published on 23 Sep 2022

Phytochemical and toxicological evaluation of Zephyranthes citrina

in Predictive Toxicology

Muhammad Haseeb Ur Rehman
Uzma Saleem
Bashir Ahmad
Memoona Rashid

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007310

12,402 views
39 citations

Original Research

Published on 17 Dec 2019

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma

in Molecular and Cellular Oncology

Paige Baldwin
Rostislav Likhotvorik
Nabeela Baig
Jodie Cropper
Ruth Carlson
Raushan Kurmasheva
Srinivas Sridhar

Frontiers in Oncology

doi 10.3389/fonc.2019.01416

5,872 views
24 citations

Original Research

Published on 26 Oct 2023

Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project

in Breast Cancer

Marina Elena Cazzaniga
Antonio Ciaccio
Romano Danesi
Francois P. Duhoux
Corrado Girmenia
Kalhil Zaman
Henrik Lindman
Fabrizio Luppi
Dimitrios Mavroudis
Ida Paris

Frontiers in Oncology

doi 10.3389/fonc.2023.1247270

11,760 views
8 citations

Mini Review

Published on 14 Jun 2022

Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences

in Translational Medicine

Ana Cardeña-Gutiérrez
Mónica López Barahona

Frontiers in Medicine

doi 10.3389/fmed.2022.908752

5,694 views
9 citations

Original Research

Published on 22 Dec 2023

Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience

in Cancer Immunity and Immunotherapy

Katarzyna Pawinska-Wasikowska
Malgorzata Czogala
Szymon Skoczen
Marta Surman
Monika Rygielska
Teofila Ksiazek
Agnieszka Pac
Aleksandra Wieczorek
Jolanta Skalska-Sadowska
Magdalena Samborska

Frontiers in Immunology

doi 10.3389/fimmu.2023.1268993

6,105 views
3 citations

Original Research

Published on 10 Sep 2024

Acylfulvenes covalently interact with thioredoxin as an additional cancer target

in Molecular Sciences

Laura Slappendel
Xiaodan Liu
Michael R. Macarthur
Charles M. Sharpless
Shana J. Sturla

Frontiers in Chemical Biology

doi 10.3389/fchbi.2024.1462351

1,719 views

Original Research

Published on 18 Sep 2023

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

in Pharmacoepidemiology

Patricia Marques Soares Valente
Paula Nogueira da Silva
Licínio Esmeraldo da Silva
Wolney de Andrade Martins
Selma Rodrigues de Castilho

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1099545

2,281 views
2 citations

Case Report

Published on 24 Nov 2025

Complete remission of advanced MSI-H rectal cancer in a young patient treated with nivolumab: a case report and critical appraisal of the literature

in Gastrointestinal Cancers: Colorectal Cancer

Marian Liberko
Renata Soumarova

Frontiers in Oncology

doi 10.3389/fonc.2025.1680308

1,600 views

Review

Published on 25 Feb 2025

Exploring manzamine a: a promising anti-lung cancer agent from marine sponge Haliclona sp

in Experimental Pharmacology and Drug Discovery

Min Su
Jie Zhu
Luyuan Bai
Yu Cao
Shaohui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1525210

3,361 views
14 citations

Articles

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study

Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review

Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia

Case report: Ultrahypofractionated palliative breast radiotherapy for a fungating invasive mammary carcinoma

Effect on Platelet Function of Metal-Based Nanoparticles Developed for Medical Applications

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, Nab-Paclitaxel)

Phytochemical and toxicological evaluation of Zephyranthes citrina

Nanoformulation of Talazoparib Increases Maximum Tolerated Doses in Combination With Temozolomide for Treatment of Ewing Sarcoma

Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project

Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences

Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience

Acylfulvenes covalently interact with thioredoxin as an additional cancer target

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

Complete remission of advanced MSI-H rectal cancer in a young patient treated with nivolumab: a case report and critical appraisal of the literature

Exploring manzamine a: a promising anti-lung cancer agent from marine sponge Haliclona sp